No Detail Found!

Pathological Assessmentof Tumor Response in a Neo-adjuvant Therapy Treated Resections for Osteosarcomas.

Author(s)
Syed Saad Gardezi Shaukat Khanum Memorial Cancer Hospital & Research Centre (SKMCH&RC), Lahore, Pakistan
Iftikar Ali Rana Shaukat Khanum Memorial Cancer Hospital & Research Centre (SKMCH&RC), Lahore, Pakistan
Asif Loya Shaukat Khanum Memorial Cancer Hospital & Research Centre (SKMCH&RC), Lahore, Pakistan
Sajid Mushtaq Shaukat Khanum Memorial Cancer Hospital & Research Centre (SKMCH&RC), Lahore, Pakistan
Noreen Akhter Shaukat Khanum Memorial Cancer Hospital & Research Centre (SKMCH&RC), Lahore, Pakistan
Muhammad Tariq Mehmood Shaukat Khanum Memorial Cancer Hospital & Research Centre (SKMCH&RC), Lahore, Pakistan
Abstract
Objective: To assess of the pathologic response of patients of osteosarcoma, after neoadjuvant chemotherapy. Study Design: Descriptive study. Place and Duration of Study: Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore from Jan 2016 to Aug 2016. Material and Methods: A total of 60 cases of osteosarcoma found suitable by inclusion criteria were included in this study. Demographic details such as name, sex and age were collected. All specimens were grossed and staged according to CAP guidelines. Tumor response was assessed by two pathologists and graded as good and poor response. Results: Sixty percent (n=36) of patients were between 7-18 years of age while 40% (n=24) of patients were between 19-45 years of age. Mean age was 17.65 years. A total of 58.33% (n=35) of patients were males and 41.67% (n=25) of patients were females. Thirty percent (n=18) of the patients had good response, while 70% (n=42) of patients had poor response to chemotherapy. Conclusion: We concluded that the assessment of pathologic response of osteosarcoma after neoadjuvant chemotherapy in terms of good response and poor response is a useful tool for the pathologist and the oncologist. It gives us useful information regarding patient's response to neoadjuvant chemo radiotherapy that also helps in determining the further management and overall survival rate of the patient.
Publication Details
Page(s) 697-700
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 68, Issue: 4, Year: 2018

Request the full text from PASTIC

References
SavageSA, 2011.Using epidemiology and genomics to understand osteosarcoma etiology,Sarcoma 548151 13 -
QureshiA,AhmadZ,AzamM,IdreesR, 2010.Epidemiological data for common bone sarcomas,Asian Pac J Cancer Prev 11 393 -5
2013.,Annual cancer registry report-2013. Shaukat Khanum Memorial Cancer Hospital & Research Center p05 -
RejniakKA,LloydMC,ReedDR,BuiMM, 2015.Diagnostic assessment of osteosarcoma chemoresistance based on virtual clinical trials,Med Hypotheses 85 348 -54
HaddoxCL,HanG,AnijarL,BinitieO,LetsonGD,BuiMM, 2014.Osteosarcoma in pediatric patients and young adults: A single institution retrospective review of presentation, therapy, and outcome,Sarcoma 402509 -
XuM,XuSF,YuXC, 2014.Clinical analysis of osteosarcoma patients treated with high-dose methotrexate-free neoadjuvant chemotherapy,Curr Oncol 21 e678 -84
O'Kane,GM , Cadoo,KA , Walsh,EM , Emerson,R , Dervan,P , O'Keane,C, 2015.Perioperative chemotherapy in the treatment of osteosarcoma: A 26-year single institution review,Clin Sarcoma Res 5 17 -
DorotheC,BielackSS, 2006.Current Strategies of Chemotherapy in Osteosarcoma,Intl Orthop 30 445 -51
GellerDS,GorlickR.,Osteosarcoma, 2010.A review of diagnosis, management, and treatment strategies,Clin Adv Hematol Oncol 8 705 -18
0

Citations

0

Downloads

108

Views